Preclinical studies have shown that inhibition of HIF-1 signaling activity can significantly reduce cancer growth, and research is currently underway to identify HIF-1 inhibitors and validate their efficacy in antitumor therapy [36]. The gene discussed is HIF1A; the disease is cancer.